A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia

NCT02008773 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Valacyclovir HCI 500 mg tablets
DRUG: placebo

Sponsor

Indiana University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]